Cidara therapeutics to host virtual r&d day to discuss cd388 as a potential universal, once-per-flu season preventative of seasonal and pandemic influenza on may 22, 2025

San diego, may 15, 2025 (globe newswire) -- cidara therapeutics, inc. (nasdaq: cdtx) (the company), a biotechnology company using its proprietary cloudbreak® platform to develop drug-fc conjugate (dfc) therapeutics, today announced that it will host a virtual research and development (r&d) day on thursday, may 22, 2025, from 10:00 to 11:30 am et. to register, click here.
UVV Ratings Summary
UVV Quant Ranking